Finance

Lists
MCK:NYSE
McKesson Corp
US$ १,०६९.४३
+०.६८%
(+७.२७) 1D
US$ १,०६९.४३
०.००% (०.००)
After hours
Closed: नोभेम्बर २०, १६:००:०५ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCK...
Open
US$ १,०७६.७२
High
US$ १,०८८.१४
Low
US$ १,०६६.९४
Mkt. cap
१.२३ खरब
Avg. vol.
७.०५ लाख
Volume
८.७० लाख
Dividend
०.३५%
Quarterly dividend
US$ ०.९४
Ex-dividend date
२०२६ डिसेम्बर १
P/E ratio
२७.५२
52-wk high
US$ १,१२१.५०
52-wk low
US$ ७२३.६८
EPS
US$ ३८.८६
Beta
०.२७
Shares outstanding
११.५५ करोड
No. of employees
४२ हजार
Open
US$ १,०७६.७२
High
US$ १,०८८.१४
Low
US$ १,०६६.९४
Mkt. cap
१.२३ खरब
Avg. vol.
७.०५ लाख
Volume
८.७० लाख
Dividend
०.३५%
Quarterly dividend
US$ ०.९४
Ex-dividend date
२०२६ डिसेम्बर १
P/E ratio
२७.५२
52-wk high
US$ १,१२१.५०
52-wk low
US$ ७२३.६८
EPS
US$ ३८.८६
Beta
०.२७
Shares outstanding
११.५५ करोड
No. of employees
४२ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
२ दिन पहिले
McKesson stock broadens healthcare reach with Option Care deal
Yahoo! Finance Canada
Yahoo! Finance Canada
·
३ दिन पहिले
Two Deals and a Higher Target: UBS’s Call on McKesson (MCK)
Financial Times
Financial Times
·
१ महिना पहिले
McKesson and CD&R strike $5.8bn deal to buy infusion services provider
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
About McKesson Corp
CEOBrian S. Tyler
Employees४२.३ हजार
Founded१८३५
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 13 analysts giving stock ratings to MCK in the past 3 months
Strong buy
Buy
11
Hold
2
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for MCK in the last 3 months.
Highest
Current US$ १,०६९.४३
US$ १,२६०.०० (+१७.८२%)
Average
US$ १,१६६.९२ (+९.१२%)
Lowest
US$ ९१३.०० (-१४.६३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Maintained
US$ १,२३५.००
+१५.५%
11/17/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
US$ १,२५०.००
+१६.९%
11/10/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
US$ १,२५५.००
+१७.४%
11/10/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
US$ १,०५०.००
-१.८%
11/05/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$ १,२००.००
+१२.२%
11/05/2026
Kevin Caliendo
UBS
Buy
Reiterated
US$ १,२५०.००
+१६.९%
11/05/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
US$ १,२००.००
+१२.२%
11/05/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
US$ १,२६०.००
+१७.८%
11/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$ १,२००.००
+१२.२%
11/05/2026
Ryan Halsted
RBC Capital
Hold
Reiterated
US$ ९६५.००
-९.८%
11/04/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
US$ १,२२५.००
+१४.५%
11/05/2026
George Hill
Deutsche Bank
Buy
Maintained
US$ ९१३.००
-१४.६%
10/06/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
10/05/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
US$ ९३३.००
-१२.८%
08/11/2026
Daniel Grosslight
Citi
Buy
Reiterated
US$ १,०००.००
-६.५%
08/10/2026
Max Smock
William Blair
Buy
Reiterated
-
-
05/08/2026
Last report
२०२६ नोभेम्बर ४
Fiscal period
Q2 2027
US$ ११.६८ / US$ १०.७५
+८.६२%beat
Revenue / Est. (USD)
१.११ खरब / १.१० खरब
+०.९१%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१.०६ खरब
९६.३० अरब
१.०५ खरब
१.११ खरब
Cost of goods sold
१.०२ खरब
९२.२५ अरब
१.०२ खरब
१.०७ खरब
Cost of revenue
१.०२ खरब
९२.२५ अरब
१.०२ खरब
१.०७ खरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.०३ अरब
१.९२ अरब
२.२६ अरब
२.२७ अरब
Operating expense
२.०३ अरब
१.९२ अरब
२.२६ अरब
२.२७ अरब
Total operating expenses
१.०५ खरब
९४.१७ अरब
१.०४ खरब
१.०९ खरब
Operating income
१.६४ अरब
२.१३ अरब
१.४२ अरब
१.६४ अरब
Other non operating income
७.४० करोड
-१५.६० करोड
६.६० करोड
६.३० करोड
EBT including unusual items
१.६३ अरब
२.१२ अरब
१.३१ अरब
१.५६ अरब
EBT excluding unusual items
१.६५ अरब
२.१० अरब
१.४१ अरब
१.६० अरब
Income tax expense
३८.०० करोड
२७.०० करोड
२७.६० करोड
२६.६० करोड
Effective tax rate
२३.३१%
१२.७१%
२१.१०%
१७.०३%
Other operating expenses
-
-
-
-
Net income
१.१९ अरब
१.६८ अरब
६१.४० करोड
१.२२ अरब
Net profit margin
१.१२%
१.७५%
०.५८%
१.१०%
Earnings per share
९.३४
११.६९
९.९३
११.६८
Interest and investment income
-
१७.९० करोड
-
-
Interest expense
-६.३० करोड
-६.१० करोड
-७.७० करोड
-१०.५० करोड
Net interest expenses
-६.३० करोड
११.८० करोड
-७.७० करोड
-१०.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.८३ अरब
२.१९ अरब
१.६२ अरब
१.८३ अरब
Gain or loss from assets sale
-
-४८.८० करोड
-६०.०० लाख
-१.८० करोड
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू